REPORT ID 4758

United States Polio Vaccine Market Report 2017

Publish Date
19-Dec-17
Pages
110
Format
Electronic (PDF)

In this report, the United States Polio Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Polio Vaccine in these regions, from 2012 to 2022 (forecast).

United States Polio Vaccine market competition by top manufacturers/players, with Polio Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Bibcol
    Sanofi
    Merck & Co
    Pfizer
    Beijing Tiantan Biological
    Bio-Med
    Panacea Biotec Ltd
    Adithya Vaccine Pharma
    Sinovac Biotech Ltd
    IPOL
    Halfkin Bio-Pharmaceuticals Corporation Ltd
    Aventis Pasteur

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    By Type
        Inactivated Polio Vaccine (IPV)
        Oral Polio Vaccine (OPV)
    By Type 2
        Live Attenuated Vaccine
        Inactivated Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinics
    Public Services
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Polio Vaccine Market Report 2017
1 Polio Vaccine Overview
    1.1 Product Overview and Scope of Polio Vaccine
    1.2 Classification of Polio Vaccine by Product Category
        1.2.1 United States Polio Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Polio Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Inactivated Polio Vaccine (IPV)
        1.2.4 Oral Polio Vaccine (OPV)
    1.3 United States Polio Vaccine Market by Application/End Users
        1.3.1 United States Polio Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Public Services
        1.3.5 Others
    1.4 United States Polio Vaccine Market by Region
        1.4.1 United States Polio Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Polio Vaccine Status and Prospect (2012-2022)
        1.4.3 Southwest Polio Vaccine Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Polio Vaccine Status and Prospect (2012-2022)
        1.4.5 New England Polio Vaccine Status and Prospect (2012-2022)
        1.4.6 The South Polio Vaccine Status and Prospect (2012-2022)
        1.4.7 The Midwest Polio Vaccine Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Polio Vaccine (2012-2022)
        1.5.1 United States Polio Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 United States Polio Vaccine Revenue and Growth Rate (2012-2022)

2 United States Polio Vaccine Market Competition by Players/Suppliers
    2.1 United States Polio Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Polio Vaccine Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Polio Vaccine Average Price by Players/Suppliers (2012-2017)
    2.4 United States Polio Vaccine Market Competitive Situation and Trends
        2.4.1 United States Polio Vaccine Market Concentration Rate
        2.4.2 United States Polio Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Polio Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Polio Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Polio Vaccine Sales and Market Share by Region (2012-2017)
    3.2 United States Polio Vaccine Revenue and Market Share by Region (2012-2017)
    3.3 United States Polio Vaccine Price by Region (2012-2017)

4 United States Polio Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Polio Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Polio Vaccine Revenue and Market Share by Type (2012-2017)
    4.3 United States Polio Vaccine Price by Type (2012-2017)
    4.4 United States Polio Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Polio Vaccine Sales (Volume) by Application (2012-2017)
    5.1 United States Polio Vaccine Sales and Market Share by Application (2012-2017)
    5.2 United States Polio Vaccine Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Polio Vaccine Players/Suppliers Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Polio Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bibcol
        6.2.2 Polio Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Sanofi
        6.3.2 Polio Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck & Co
        6.4.2 Polio Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck & Co Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Pfizer
        6.5.2 Polio Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Pfizer Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Beijing Tiantan Biological
        6.6.2 Polio Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Beijing Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bio-Med
        6.7.2 Polio Vaccine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Panacea Biotec Ltd
        6.8.2 Polio Vaccine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Adithya Vaccine Pharma
        6.9.2 Polio Vaccine Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Adithya Vaccine Pharma Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sinovac Biotech Ltd
        6.10.2 Polio Vaccine Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sinovac Biotech Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 IPOL
    6.12 Halfkin Bio-Pharmaceuticals Corporation Ltd
    6.13 Aventis Pasteur

7 Polio Vaccine Manufacturing Cost Analysis
    7.1 Polio Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Polio Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Polio Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Polio Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Polio Vaccine Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Polio Vaccine Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Polio Vaccine Sales Volume Forecast by Type (2017-2022)
    11.3 United States Polio Vaccine Sales Volume Forecast by Application (2017-2022)
    11.4 United States Polio Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer